In PReSTaR vision, collaboration with pharmaceutical companies represents a strategic opportunity to promote shared and innovative projects. This synergy can accelerate the development of effective therapies, while upholding scientific integrity and transparency. Involving parent-patient associations further strengthens the process by placing the real needs of patients at the heart of research. With this aim, PReSTaR strives to serve as a bridge between paediatric rheumatology researchers, industry, and the community to achieve meaningful health impact.
Operationally, PReSTaR provides targeted scientific, technical, and administrative support to ensure efficient management and seamless execution of clinical research activities. This includes formal input on the development of Case Report Forms (CRFs), as well as general administrative and procedural assistance to participating satellite centers through the organization of regular teleconferences and newsletters. Furthermore, PReSTaR contributs in drafting data entry manuals for investigators to promote accurate and standardized data collection procedures.
For data collection and web development, PReSTaR is responsible for implementing and disseminating feasibility assessments to identify suitable satellite centers, and for the development and validation of eCRF. It supports automated score calculations for clinical measures, such as ACR response criteria and JADAS calculation, facilitates the validation and distribution of surveys and parent/patient-reported outcomes (PROs), manages data export processes.
Finally, it ensures standardized classification of safety events through MedDRA dictionary coding.